News & Updates

Maternal use of the migraine drug triptans before or during pregnancy does not appear to put infants at risk of developing neurodevelopmental disorders, according to a study.

For older adults who received treatment with antipsychotics to manage delirium, medication discontinuation leads to better outcomes, including reduced risks of all-cause rehospitalization and mortality, compared with continued use, according to a study.

A significant association exists between refractory gastroesophageal disease (RGERD) and increased methane (CH4) levels, reports a study.

Approximately one in six atrial fibrillation (AF) patients who sustained a stroke experiences another one within 5 years despite receiving modern preventive therapy, according to a systematic review and meta-analysis.

A study using data from the CARTaGENE cohort links lower estimated glomerular filtration rate (eGFR) to cognitive impairment and brain alterations.

Substantial changes in remnant cholesterol levels over time are associated with a heightened risk of stroke in the general population, according to a study.

New drug applications approved by US FDA as of 16-30 April 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

New drug applications approved by US FDA as of 1-15 May 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Consuming high amounts of dietary fibre helps reduce the risk of stroke and of all-cause mortality among individuals who have already survived a stroke, according to a study.